Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 459
Selected: 0
NCT IDTitle
NCT06300177D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
NCT06962267A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT02332499Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703)
NCT05068921A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy
NCT02586337Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
NCT05409326A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
NCT05020652A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
NCT04234607A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)
NCT07266116Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
NCT07738679Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors
NCT06507891A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
NCT06760182Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis
NCT04796623A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer
NCT01846650A Bioequivalence Study of Capecitabine Tablets
NCT04768699Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.
NCT07398859Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
NCT07047365TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT04846634Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)
NCT05045872Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT04925141A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
NCT05922345Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
NCT05344729Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects
NCT07165951Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
NCT01886053A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT06439381Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps
NCT07529925A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis
NCT04273815A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
NCT06415903A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer
NCT05634473A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
NCT07512583Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors
NCT02752516A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics
NCT05894421TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT06251947Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
NCT04412564A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor
NCT03855384Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN)
NCT05867563Clinical Trial Evaluating the Safety of the TQB2103 for Injection
NCT07545213Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis
NCT05380934A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects
NCT02809534A Study of Anlotinib in Patients With Hepatocellular Carcinoma
NCT06527144A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT02944864A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics
NCT06662760Clinical Trial of TQB3002 in Patients With Advanced Cancers
NCT02671942A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients
NCT06165822A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
NCT05340530To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects
NCT05834543Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT07156643A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.
NCT03855358A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
NCT01806376A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics